Liraglutide Peptide API — Peptides
WHO-GMP Certified Commercial Pack · Product Code: AKP-API-03

Liraglutide Peptide API

Peptide API Overview: Acylated GLP-1 analogue peptide API engineered for once-daily type 2 diabetes and obesity sterile injectable drug products. Indicated for T2DM, Obesity. Supplied as lyophilized crystalline powder (Purity ≥ 99.0% HPLC, CAS 204656-20-2) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Supplied as Lyophilized Peptide API (Purity ≥ 99.0% (HPLC)) within Pharmaceutical Peptide APIs, complying with EP / USP / ICH Q7 Peptide API Monograph with batch HPLC/MS CoA and regulatory documentation for African and global formulators.
Item Code (SKU)AKP-API-03
CAS Registry No.204656-20-2
Catalog ReferenceAKP-API-03 · SN API-03
Therapeutic SectorPharmaceutical Peptide APIs
Dosage FormLyophilized Peptide API
Active IngredientLiraglutide (CAS 204656-20-2)
Strength / PurityPurity ≥ 99.0% (HPLC)
Clinical IndicationT2DM, Obesity
Specification StandardEP / USP / ICH Q7 Peptide API Monograph
Packaging FormatSealed Type I Glass Vial · Nitrogen Headspace (Bulk / Custom Weights)
Shelf Life24–36 Months (Lyophilized at -20°C)
Storage ConditionsStore lyophilized at -20°C (short-term 2–8°C); protect from moisture and light
Minimum Order Quantity50 Vials
Regulatory / Analytical DocsFull eCTD / ACTD Modules 1–5 + Zone IVb Stability Available
African & Global NRA ReadinessNAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA
Stock AvailabilityIn Stock · Immediate Commercial Dispatch
Supply StatusCommercial & Regulatory Export Ready

Related Peptides & Pharmaceutical Peptide APIs